...
首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Identification and pharmacological characterization of the anti-inflammatory principal of the leaves of dwarf elder (Sambucus ebulus L.).
【24h】

Identification and pharmacological characterization of the anti-inflammatory principal of the leaves of dwarf elder (Sambucus ebulus L.).

机译:矮老叶(Sambucus ebulus L.)的抗炎成分的鉴定和药理学表征。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIM OF THE STUDY: The performed investigations aimed on the identification of the anti-inflammatory principal of extracts of leaves of Sambucus ebulus L. (dwarf elder) in order to rationalize the traditional use of this plant for the treatment of chronically inflammatory diseases. MATERIALS AND METHODS: Dwarf elder leaf extract was subjected to activity guided fractionation using inhibition of TNFalpha induced expression of vascular cell adhesion molecule 1 (VCAM-1) on the surface of human umbilical vein endothelial cells (HUVECs) as monitoring tool (positive control: parthenolide 10muM, VCAM-1 expression (% of control): 5.35+/-0.38%). RESULTS: Bio-guided isolation resulted in identification of ursolic acid as anti-inflammatory principal. Besides its inhibitory effects against TNFalpha induced expression of VCAM-1 (IC(50) 6.25 muM), ursolic acid inhibits also TNFalpha induced expression of ICAM-1 (IC(50) value between 3.13 and 6.25 muM) (positive control: parthenolide 10 muM, ICAM-1 expression (% of control): 38.89+/-16.6%). Toxic effects of ursolic acid on HUVECs can be drastically reduced using an enriched extract instead of the pure compound. CONCLUSIONS: Our findings suggest an additional mechanism of the anti-inflammatory activity of ursolic acid by demonstrating its ability to inhibit TNFalpha-stimulated expression of VCAM-1 and ICAM-1 and support the traditional use of extracts and preparations of Sambucus ebulus L., rich in ursolic acid, for the treatment of chronically inflammatory processes.
机译:研究目的:进行的研究旨在鉴定接骨木(矮小老年人)叶子提取物的抗炎成分,以合理化该植物用于治疗慢性炎症疾病的传统用途。材料与方法:以抑制TNFalpha诱导的人脐静脉内皮细胞(HUVEC)表面上血管细胞粘附分子1(VCAM-1)的表达为基础,对矮叶老叶提取物进行活性指导的分级分离(阳性对照:甘菊内酯10μM,VCAM-1表达(对照%):5.35 +/- 0.38%。结果:生物引导分离导致鉴定了乌索酸作为抗炎药。熊果酸除了对TNFalpha诱导的VCAM-1表达(IC(50)6.25μM)有抑制作用外,还抑制TNFalpha诱导的ICAM-1表达(IC(50)值在3.13和6.25μM之间)(阳性对照:单性酚10 muM,ICAM-1表达(对照的%):38.89 +/- 16.6%。使用丰富的提取物代替纯化合物可以大大降低熊果酸对HUVEC的毒性作用。结论:我们的研究结果表明熊果酸具有抑制TNFα刺激的VCAM-1和ICAM-1表达的能力,并支持传统用途的接骨木和接骨木(Sambucus Ebulus L.)的提取物,表明其具有抗炎活性的另一种机制,富含熊果酸,用于治疗慢性炎症过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号